Home/Filings/4/0001104659-22-123232
4//SEC Filing

Darakjian Erin 4

Accession 0001104659-22-123232

CIK 0001832511other

Filed

Nov 29, 7:00 PM ET

Accepted

Nov 30, 4:05 PM ET

Size

5.6 KB

Accession

0001104659-22-123232

Insider Transaction Report

Form 4
Period: 2022-11-28
Darakjian Erin
Interim CFO, Senior VP & CAO
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-11-28+100,000100,000 total
    Exercise: $4.62Exp: 2032-11-28Class A Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]The option vests and becomes exercisable with respect to 25% of the shares on each of October 18, 2023, October 18, 2024, October 18, 2025 and October 18, 2026, subject to the Reporting Person's continued service through the applicable vesting date.

Issuer

P3 Health Partners Inc.

CIK 0001832511

Entity typeother

Related Parties

1
  • filerCIK 0001953468

Filing Metadata

Form type
4
Filed
Nov 29, 7:00 PM ET
Accepted
Nov 30, 4:05 PM ET
Size
5.6 KB